Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Treasury Shares (2019 - 2025)

Tvardi Therapeutics' Treasury Shares history spans 7 years, with the latest figure at $25846.0 for Q1 2025.

  • On a quarterly basis, Treasury Shares rose 271.78% to $25846.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $25846.0, a 271.78% increase, with the full-year FY2024 number at $26638.0, down 43.56% from a year prior.
  • Treasury Shares hit $25846.0 in Q1 2025 for Tvardi Therapeutics, down from $26638.0 in the prior quarter.
  • Over the last five years, Treasury Shares for TVRD hit a ceiling of $976799.0 in Q2 2024 and a floor of $6952.0 in Q1 2024.
  • Historically, Treasury Shares has averaged $477869.8 across 5 years, with a median of $576544.0 in 2021.
  • Biggest five-year swings in Treasury Shares: plummeted 99.0% in 2024 and later surged 271.78% in 2025.
  • Tracing TVRD's Treasury Shares over 5 years: stood at $576544.0 in 2021, then crashed by 94.62% to $31043.0 in 2022, then soared by 52.03% to $47194.0 in 2023, then tumbled by 43.56% to $26638.0 in 2024, then dropped by 2.97% to $25846.0 in 2025.
  • Business Quant data shows Treasury Shares for TVRD at $25846.0 in Q1 2025, $26638.0 in Q4 2024, and $967924.0 in Q3 2024.